Aurobindo Pharma Receives US FDA Observations For Two Of Its Facilities
Posted by
www.biotecnika.org
Aurobindo Receives USFDA Observations Aurobindo Pharma, in a
statement, said the US Food and Drug Administration had issued Form
483 with four observations each for two of its manufacturing
facilities. They include the Unit 5 API facility at Pashamailaram &
Unit 8 API facility at Gaddapotharam in Hyderabad. The Pharma giant
highlighted that the latest […]
The post Aurobindo Pharma Receives US FDA Observations For Two Of Its
Facilities appeared first on Rasayanika .
https://www.rasayanika.com/2019/11/07/aurobindo-pharma-receives-us-fda-observations-for-two-of-its-facilities/
Uncategorized
Subscribe to:
Post Comments (Atom)
Post a Comment